Vanguri, R. S., Fenn, K. M., Kearney, M. R., Wang, Q., Guo, H., Marks, D. K., Chin, C., Alcus, C. F., Thompson, J. B., Leu, C.-S., Hibshoosh, H., Kalinsky, K. M., Mathews, J. C., Nadeem, S., Hollmann, T. J., & Connolly, E. P. (2022). Tumor Immune Microenvironment and Response to Neoadjuvant Chemotherapy in Hormone Receptor/HER2+ Early Stage Breast Cancer. Clinical Breast Cancer, 22(6), 538–546. https://doi.org/10.1016/j.clbc.2022.04.002